4
Changes in Ownership
Atrium Therapeutics, Inc. Filed Acc 0001193125-26-397971
Chief Scientific Officer gave up 11,216 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Younis Husam Chief Scientific Officer | 2026-09-18 | Shares withheld for taxes | −11,216 | $8.95 | $100,383 | 41,441 | D |
Loading xslF345X06/ownership.xml…